Novartis Korea assigned Zelmac promotion to Uthis.

Novartis Korea announced to assign a product detailing activity of Zelmac (tegacerod) sales promotion in local private clinic markets under a certain agreement with Uthis company, a specialized out-sourcing company in Korea. Zelmac is a drug approved for the treatment of irritable colon syndrome and chronic constipation in Korea.

According to the agreement, Uthis starts detailing of Novarti...